Search

everythinglearnresearchcommunity

for

Search:↓

Etoposide makes radiation therapy more effective against tumors without major side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Further research is needed to develop effective cancer prevention strategies.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Enhancing immune response can improve cancer treatment effectiveness.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.